Staar Surgical
Staar Surgical Company, commonly referred to as Staar, is a leading innovator in the ophthalmic medical device industry, headquartered in the United States. Founded in 1982, the company has made significant strides in the development of advanced intraocular lenses (IOLs) and minimally invasive surgical technologies, particularly for cataract and refractive procedures. With a strong presence in key markets across North America, Europe, and Asia, Staar Surgical is renowned for its proprietary lens designs, including the Visian ICL, which offers unique benefits for patients with myopia and hyperopia. The company’s commitment to research and development has positioned it as a market leader, achieving notable milestones such as FDA approvals and expanding its product portfolio to enhance patient outcomes. Staar continues to set benchmarks in the ophthalmic sector, driven by its dedication to innovation and quality.
DitchCarbon Score
How does Staar Surgical's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Staar Surgical's score of 23 is higher than 79% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Staar Surgical's reported carbon emissions
In 2022, Staar Surgical reported total carbon emissions of approximately 1,301,780 kg CO2e, with Scope 1 emissions at about 63,200 kg CO2e and Scope 2 emissions at approximately 1,238,580 kg CO2e. This marked an increase from 2021, where total emissions were about 1,009,640 kg CO2e, with Scope 1 at approximately 64,570 kg CO2e and Scope 2 at about 945,070 kg CO2e. The company's emissions have fluctuated over the years, with total emissions in 2021 being about 1,009,640 kg CO2e, down from approximately 1,019,280 kg CO2e in 2020. In 2019, Staar Surgical's total emissions were about 1,001,660 kg CO2e, with Scope 1 at approximately 53,030 kg CO2e and Scope 2 at about 948,640 kg CO2e. As of 2023, no specific emissions data has been reported, and the company has not disclosed any reduction targets or initiatives under the Science Based Targets initiative (SBTi). However, Staar Surgical continues to monitor its greenhouse gas intensity, which was reported at approximately 0.0048 in 2023, indicating ongoing efforts to manage emissions relative to revenue. Overall, while Staar Surgical has not set formal reduction targets, its emissions data reflects a commitment to tracking and potentially reducing its carbon footprint in the future.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
Add to project| 2019 | 2020 | 2021 | 2022 | |
|---|---|---|---|---|
| Scope 1 | 53,030 | 00,000 | 00,000 | 00,000 |
| Scope 2 | 948,640 | 000,000 | 000,000 | 0,000,000 |
| Scope 3 | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Staar Surgical is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
